$1.80
0.063.45%
Last update: Nov 6, 4:45 AM
Polaryx Therapeutics Inc (PLYX) Stock Price, Quote, News & History
PLYXNASDAQ
Polaryx Therapeutics (NASDAQ: PLYX) stock climbs on Thursday following a $10M private placement to launch its Phase 2 SOTERIA trial for rare lysosomal storage...
You can purchase shares of Polaryx Therapeutics (NASDAQ:PLYX) through any online brokerage.
Other companies in Polaryx Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Polaryx Therapeutics has a consensus price target of $7.50.
The stock price for Polaryx Therapeutics (NASDAQ: PLYX) is $1.81 last updated November 6, 2026 at 4:45 AM EST.
There are no upcoming dividends for Polaryx Therapeutics.
Polaryx Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Polaryx Therapeutics.
Polaryx Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the...
